EUROPA

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease - The Lancet -2003

Brief Summary:

In patients with stable CAD without heart failure, perindopril reduces CV mortality, MI, or cardiac arrest, as compared to placebo.

Reference: http://www.ncbi.nlm.nih.gov/pubmed/13678872

Comments